Figure 7. Immune analysis based on high- and low-risk groups. (A) Immune-related pathway GSVA between high- and low-risk groups. (B) Box plot of 22 immune cells in the high- and low-risk groups of the training cohort. (C) Box plot of 22 immune cells in the high- and low-risk groups of the validation cohort.